SHH · Key Statistics

China National Medicines Corporation Ltd. (600511.SS) Key Statistics

$27.80 SHH: 600511.SS Market Cap $20.12B

Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for China National Medicines Corporation Ltd. (600511.SS), each with what it measures. Figures are trailing twelve months or the most recent reported period.

Valuation

Metric	Value
P/E ratioShare price divided by earnings per share.	10.42
P/B ratioShare price divided by book value per share.	1.07
P/S ratioMarket value divided by annual revenue.	0.38

Profitability

Metric	Value
Gross marginRevenue left after the direct cost of goods sold.	6.51%
Operating marginRevenue left after operating costs.	3.34%
Net marginRevenue left after every cost, including tax and interest.	3.60%
Return on equityProfit as a percentage of shareholders’ equity.	9.88%
Return on assetsProfit as a percentage of total assets.	3.57%

Financial health

Metric	Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.	2.18
Quick ratioThe same, excluding inventory.	1.77
Debt to equityTotal borrowings against shareholders’ equity.	0.03

Per share and size

Metric	Value
Earnings per shareProfit attributable to each share.	$2.56
Book value per shareShareholders’ equity divided by shares outstanding.	$24.93
Shares outstandingShares currently issued.	754,502,998
Market capitalisationShare price times shares outstanding.	$20.12B
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.	$0
EmployeesReported headcount.	3,024

Dividend

Metric	Value
Dividend yieldAnnual dividend as a percentage of the share price.	3.00%
Payout ratioShare of profit paid out as dividends.	31.26%

China National Medicines Corporation Ltd. (600511.SS) statistics — frequently asked questions

What is China National Medicines Corporation Ltd.'s P/E ratio?

China National Medicines Corporation Ltd. (600511.SS) trades on a price-to-earnings ratio of 10.42.

What is China National Medicines Corporation Ltd.'s return on equity?

China National Medicines Corporation Ltd. (600511.SS) reports a return on equity of 9.88%, meaning it generated that much profit for every dollar of shareholders' equity.

How much debt does China National Medicines Corporation Ltd. carry?

China National Medicines Corporation Ltd. (600511.SS) has a debt-to-equity ratio of 0.03, which compares total borrowings with shareholders' equity.

What is China National Medicines Corporation Ltd.'s profit margin?

China National Medicines Corporation Ltd. (600511.SS) keeps 3.60% of revenue as net profit after every cost, including tax and interest.

Related stock screens

High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks All stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.